Effects of the COVID-19 pandemic on surgical treatment for thoracic malignant tumor cases in Japan: a national clinical database analysis.

IF 1.7 4区医学 Q2 SURGERY

Surgery Today Pub Date : 2025-02-01 Epub Date: 2024-12-07 DOI:10.1007/s00595-024-02907-w

Yasushi Shintani, Hiroyuki Yamamoto, Yukio Sato, Masayoshi Inoue, Keisuke Asakura, Hiroyuki Ito, Hidetaka Uramoto, Yoshinori Okada, Toshihiko Sato, Mariko Fukui, Yasushi Hoshikawa, Toyofumi Fengshi Chen-Yoshikawa, Masayuki Chida, Norihiko Ikeda, Ichiro Yoshino

{"title":"Effects of the COVID-19 pandemic on surgical treatment for thoracic malignant tumor cases in Japan: a national clinical database analysis.","authors":"Yasushi Shintani, Hiroyuki Yamamoto, Yukio Sato, Masayoshi Inoue, Keisuke Asakura, Hiroyuki Ito, Hidetaka Uramoto, Yoshinori Okada, Toshihiko Sato, Mariko Fukui, Yasushi Hoshikawa, Toyofumi Fengshi Chen-Yoshikawa, Masayuki Chida, Norihiko Ikeda, Ichiro Yoshino","doi":"10.1007/s00595-024-02907-w","DOIUrl":null,"url":null,"abstract":"Objective: Surgical care has been significantly affected by the COVID-19 pandemic. This study was conducted to evaluate the effects of the pandemic on lung cancer and mediastinal tumor surgery.Methods: Changes in the number of surgical procedures for lung cancer and mediastinal tumors were analyzed using the National Clinical Database of Japan. Patient characteristics, including disease stage and histological type, from 2019 to 2022 were evaluated using annual datasets.Results: Comparisons with 2019 showed that the number of patients who underwent surgery for primary lung cancer or a mediastinal tumor decreased in 2020 and then remained stable. There were no clinically significant changes in the trend over the four-year period regarding the number of patients for each clinical and pathological stage of lung cancer. Regarding mediastinal tumors, there was no significant difference in tumor size between years. There was a slight change in the selection of surgical indication during the second quarter of 2020, although its impact on annual trends in the stage distribution for lung cancer and primary disease for mediastinal tumors was minimal.Conclusions: Analyses of lung cancer and mediastinal tumor surgery cases in Japan during the COVID-19 pandemic showed no significant disease profile changes related to treatment delay.","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"265-272"},"PeriodicalIF":1.7000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11757856/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery Today","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00595-024-02907-w","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/7 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: Surgical care has been significantly affected by the COVID-19 pandemic. This study was conducted to evaluate the effects of the pandemic on lung cancer and mediastinal tumor surgery.

Methods: Changes in the number of surgical procedures for lung cancer and mediastinal tumors were analyzed using the National Clinical Database of Japan. Patient characteristics, including disease stage and histological type, from 2019 to 2022 were evaluated using annual datasets.

Results: Comparisons with 2019 showed that the number of patients who underwent surgery for primary lung cancer or a mediastinal tumor decreased in 2020 and then remained stable. There were no clinically significant changes in the trend over the four-year period regarding the number of patients for each clinical and pathological stage of lung cancer. Regarding mediastinal tumors, there was no significant difference in tumor size between years. There was a slight change in the selection of surgical indication during the second quarter of 2020, although its impact on annual trends in the stage distribution for lung cancer and primary disease for mediastinal tumors was minimal.

Conclusions: Analyses of lung cancer and mediastinal tumor surgery cases in Japan during the COVID-19 pandemic showed no significant disease profile changes related to treatment delay.

查看原文本刊更多论文

新冠肺炎疫情对日本胸部恶性肿瘤手术治疗的影响：国家临床数据库分析

目的：新冠肺炎疫情对外科护理产生了重大影响。本研究旨在评估大流行对肺癌和纵隔肿瘤手术的影响。方法：利用日本国家临床数据库分析肺癌和纵隔肿瘤手术次数的变化。使用年度数据集评估2019年至2022年的患者特征，包括疾病分期和组织学类型。结果：与2019年相比，2020年因原发性肺癌或纵隔肿瘤接受手术的患者数量有所下降，随后保持稳定。在四年的时间里，肺癌的每个临床和病理阶段的患者数量没有明显的临床变化。纵隔肿瘤的肿瘤大小在不同年份间无显著差异。在2020年第二季度，手术指征的选择略有变化，尽管其对肺癌和纵隔肿瘤原发疾病分期分布的年度趋势影响很小。结论：对2019冠状病毒病大流行期间日本肺癌和纵隔肿瘤手术病例的分析显示，与治疗延迟相关的疾病特征没有明显变化。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Surgery Today 医学-外科

CiteScore

4.90

自引率

4.00%

发文量

208

审稿时长

1 months

期刊介绍： Surgery Today is the official journal of the Japan Surgical Society. The main purpose of the journal is to provide a place for the publication of high-quality papers documenting recent advances and new developments in all fields of surgery, both clinical and experimental. The journal welcomes original papers, review articles, and short communications, as well as short technical reports("How to do it"). The "How to do it" section will includes short articles on methods or techniques recommended for practical surgery. Papers submitted to the journal are reviewed by an international editorial board. Field of interest: All fields of surgery.